ERCC1 and nasopharyngeal carcinoma: Although suggested by above studies that both ERCC1 and BRCA1 might act as efficient bio markers for NSCLC and colorectal cancer patients’ sensitivity in chemotherapy, knowledge on these biomarkers in NPC is still limited [11].